Cargando…
Histone post-translational modifications in frontal cortex from human donors with Alzheimer’s disease
BACKGROUND: Alzheimer’s disease (AD) is the sixth leading cause of death and the most costly disease in the US. Despite the enormous impact of AD, there are no treatments that delay onset or stop disease progression currently on the market. This is partly due to the complexity of the disease and the...
Autores principales: | Anderson, Kyle W., Turko, Illarion V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4591557/ https://www.ncbi.nlm.nih.gov/pubmed/26435705 http://dx.doi.org/10.1186/s12014-015-9098-1 |
Ejemplares similares
-
Quantification of Histone Deacetylase Isoforms in Human Frontal Cortex, Human Retina, and Mouse Brain
por: Anderson, Kyle W., et al.
Publicado: (2015) -
Mass Spectrometry Quantification Revealed Accumulation of C-Terminal Fragment of Apolipoprotein E in the Alzheimer's Frontal Cortex
por: Wang, Meiyao, et al.
Publicado: (2013) -
Histone H3 Ser57 and Thr58 phosphorylation in the brain of 5XFAD mice
por: Anderson, Kyle W., et al.
Publicado: (2015) -
Epigenetic modifications in frontal cortex from Alzheimer's disease and bipolar disorder patients
por: Rao, J S, et al.
Publicado: (2012) -
Mass spectrometry quantification of clusterin in the human brain
por: Chen, Junjun, et al.
Publicado: (2012)